New Zealand markets open in 5 hours 28 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
192.51-1.10 (-0.57%)
As of 11:32AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 341.98B
Enterprise value 399.46B
Trailing P/E 64.75
Forward P/E 16.08
PEG ratio (5-yr expected) 0.46
Price/sales (ttm)6.24
Price/book (mrq)50.45
Enterprise value/revenue 7.26
Enterprise value/EBITDA 22.09

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 330.04%
S&P500 52-week change 330.69%
52-week high 3199.95
52-week low 3135.85
50-day moving average 3193.30
200-day moving average 3174.74

Share statistics

Avg vol (3-month) 34.71M
Avg vol (10-day) 34.56M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.09%
% held by institutions 173.41%
Shares short (13 Sept 2024) 417.79M
Short ratio (13 Sept 2024) 44.24
Short % of float (13 Sept 2024) 41.01%
Short % of shares outstanding (13 Sept 2024) 41.01%
Shares short (prior month 15 Aug 2024) 420.19M

Dividends & splits

Forward annual dividend rate 46.2
Forward annual dividend yield 43.20%
Trailing annual dividend rate 36.13
Trailing annual dividend yield 33.17%
5-year average dividend yield 44.19
Payout ratio 4202.68%
Dividend date 315 Nov 2024
Ex-dividend date 415 Oct 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 9.71%
Operating margin (ttm)34.56%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)54.26%

Income statement

Revenue (ttm)55B
Revenue per share (ttm)31.10
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA 26.12B
Net income avi to common (ttm)5.3B
Diluted EPS (ttm)2.98
Quarterly earnings growth (yoy)-32.30%

Balance sheet

Total cash (mrq)13.16B
Total cash per share (mrq)7.45
Total debt (mrq)70.94B
Total debt/equity (mrq)1,039.99%
Current ratio (mrq)0.81
Book value per share (mrq)3.84

Cash flow statement

Operating cash flow (ttm)18.64B
Levered free cash flow (ttm)19.64B